Cytosolic cleaved PINK1 represses Parkin translocation to mitochondria and mitophagy
PINK1 is a mitochondrial kinase proposed to have a role in the pathogenesis of Parkinson's disease through the regulation of mitophagy. Here, we show that the PINK1 main cleavage product, PINK1 52, after being generated inside mitochondria, can exit these organelles and localize to the cytosol,...
Saved in:
Published in | EMBO reports Vol. 15; no. 1; pp. 86 - 93 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Blackwell Publishing Ltd
01.01.2014
Nature Publishing Group UK Springer Nature B.V BlackWell Publishing Ltd |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | PINK1 is a mitochondrial kinase proposed to have a role in the pathogenesis of Parkinson's disease through the regulation of mitophagy. Here, we show that the PINK1 main cleavage product, PINK1
52,
after being generated inside mitochondria, can exit these organelles and localize to the cytosol, where it is not only destined for degradation by the proteasome but binds to Parkin. The interaction of cytosolic PINK1 with Parkin represses Parkin translocation to the mitochondria and subsequent mitophagy. Our work therefore highlights the existence of two cellular pools of PINK1 that have different effects on Parkin translocation and mitophagy.
Synopsis
The kinase PINK1, mutants of which are associated with Parkinson disease development, is thought to function in mitochondria. Here, PINK1 is shown to participate in maintaining a healthy pool of mitochondria also by functioning in the cytosol, where it interacts with Parkin.
Cleaved PINK152 is retrotranslocated from mitochondria into the cytosol.
PINK152 directly interacts with Parkin in the cytosol and prevents Parkin mitochondrial translocation.
Cytosolic PINK152 attenuates valinomycin‐induced mitophagy.
Graphical Abstract
PINK1, mutants of which are associated with Parkinson, is thought to function in mitochondria. Here, PINK1 is shown to be exported into the cytosol after cleavage, where it binds Parkin, inhibiting its mitochondrial recruitment and preventing mitophagy. |
---|---|
Bibliography: | National Institutes of Health - No. NS38370-12; No. ES017384; No. NS070276; No. 2 TL1 RR 24158-6 Thomas Hartman Foundation US Department of Defense - No. W81WXWH-08-1-0465; No. W81XWH-10-1-053 ArticleID:EMBR201337294 Parkinson's Disease Foundation ark:/67375/WNG-L8X91BXW-Z istex:5DCBEB1DBA4D55FA1194A17861A2E9CFA07FE877 Supplementary Figure S1-S3Review Process File Deutsche Forschungsgemeinschaft - No. 805231 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 These authors contributed equally to this work. |
ISSN: | 1469-221X 1469-3178 1469-3178 |
DOI: | 10.1002/embr.201337294 |